The TBRF Broad Coverage Antibody Assay (BCA) is a qualitative test designed to detect IgM and IgG antibodies to TBRF Borreliae group–specific antigens in human serum. A positive test suggests exposure to the TBRF Borreliae group. This test is unavailable for patients over 65 when ordered through physician services.
Hey Practitioners! 👋 Want to learn from New York Times best-selling author Dr. Casey Means? Join her in a 6-week bootcamp where you'll master advanced diagnostic techniques & cutting-edge treatment protocols to help your patients achieve optimal metabolic health! Sign up here!
Hey Practitioners! 👋 You won't want to miss this! Fullscript Forward is a free virtual summit where leading minds in medicine share their visions of whole person care. On October 25th, join a gathering of healthcare innovators and leaders as they share cutting edge health advancements and technology that you can implement in your practice today. Register here!